Key Highlights:
- Six of the eight stocks fell on Friday, October 23, 2026, while two rose with no announced catalyst.
- Two companies, Lunai Bioworks and Atlantic American, hold Nasdaq delisting determinations.
- Lunai Bioworks expects trading to be suspended on October 30, 2026, and delisting around November 12.
- Veea, Founder Group and Delixy Holdings have each reported regaining a Nasdaq requirement.
- Hub Cyber Security and Huachen AI Parking Management Technology carry open deficiency notices.
Which Stocks Are Dealing With Nasdaq Compliance and Delisting Notices on October 23, 2026?
Eight stocks with Nasdaq status news moved on Friday, October 23, 2026. Lunai Bioworks (NASDAQ:LNAI) fell 43.11% to $0.2674 after a staff delisting determination over its stockholders' deficit, and Atlantic American (NASDAQ:AAME) fell 15.79% to $1.33 after a determination tied to late filings. Veea (NASDAQ:VEEA) rose 23.51% to $5.18 and BIO-key (NASDAQ:BKYI) rose 29.19% to $3.54, both having returned to good standing earlier. Hub Cyber Security (NASDAQ:HUBC) fell 21.17% to $0.1590 under a market value notice, Founder Group (NASDAQ:FGL) fell 10.10% to $2.58 after regaining a shares rule, Delixy Holdings (NASDAQ:DLXY) fell 12.24% to $1.72 after clearing its bid price matter, and Huachen AI Parking Management Technology (NASDAQ:HCAI) fell 16.77% to $2.68 on a split aimed at its bid price shortfall.
Lunai Bioworks: What Happens After the Delisting Determination?
Nasdaq staff determined that Lunai does not meet the minimum stockholders' equity rule, citing a deficit of $9,024,946 at June 30, 2026. The board approved a voluntary withdrawal and will not seek a hearing. Trading is expected to be suspended at the open on October 30, a Form 25 is expected around November 2, and delisting is expected around November 12. The company does not plan over-the-counter quotation. It had already carried out 1-for-10 and 1-for-8 reverse splits to defend the bid price.
Atlantic American: Can a Hearing Keep the Stock on Nasdaq?
The insurer received a determination on October 16 after missing an October 12 deadline for overdue periodic reports. It filed its 2025 annual report that day, but first-quarter and second-quarter 2026 reports remain outstanding. A hearing request was due October 23 and triggers an automatic 15-day stay, with hearings usually held 30 to 45 days later. Earlier late-filing notices were disclosed on April 21, May 22 and August 26. At $1.33 the shares equal about 0.26 times the September 30, 2025 book value of $5.10 (calculated).
Veea: What Does Regained Compliance Mean for a Stock Up 24%?
Veea said on October 8 that it returned to full Nasdaq compliance after closing at or above $1.00 for 10 straight business days from August 31 to September 14, following a 1-for-20 reverse split. The company has not announced a catalyst for the October 23 jump. Second-quarter revenue was $176,221, cash was $886,966 on June 30, and the company also announced a rollout agreement for up to 1,000 unattended stores.
BIO-key: Is the Stock Still Under Nasdaq Supervision After Its Return?
BIO-key's shares resumed trading on the Nasdaq Capital Market on July 8, 2026, after a hearings panel found compliance with the bid price and filing standards. A 1-for-10 reverse split took effect April 30. The company stays under a Discretionary Panel Monitor until July 6, 2027. It has not announced a catalyst for the 29.19% gain, and second-quarter revenue rose 13% to $1,919,991 with a net loss of $576,852.
Hub Cyber Security: Does a Market Value Notice Follow a Compliance Win?
On August 3 Hub Cyber Security said it had regained full compliance after a delayed annual report. A letter dated September 23, disclosed September 25, then said it fails the Nasdaq market value requirement for listed securities, and the company has not announced a plan. It completed 1-for-20 and 1-for-25 reverse splits in June and September. At about 1.80 million shares, its market value is near $0.28 million (calculated), and it has not announced a catalyst for the drop.
Founder Group: How Did the Company Restore Its Publicly Held Shares Requirement?
Nasdaq flagged a minimum publicly held shares deficiency on September 21, shortly after a 100-for-1 share combination on September 1 cut Class A shares from 7,369,159 to about 73,693. The company said in October that it regained compliance but has not detailed how. It also received bid price confirmation in a February 25 letter after an earlier combination. The company has not announced a catalyst for the October 23 decline, and 2025 revenue rose 33.6% to 120.70 million ringgit.
Delixy Holdings: How Long Did the Bid Price Matter Take to Close?
Nasdaq notified the oil trader on April 23 that its shares had closed below $1.00 for 30 business days, with a deadline of October 20. A 1-for-5 reverse split began trading September 28, closes stayed at or above $1.00 from September 29 through October 12, and a letter dated October 13 closed the matter. The stock is about 16.5% below its October 16 level of $2.06 (calculated). Cash was $1.79 million against $4.00 million of debt, and the company has not announced a catalyst.
Huachen AI Parking Management Technology: Is the Split Enough for the Bid Price Rule?
The company said its 1-for-20 split, effective October 23, is meant to support compliance with the minimum bid price rule, and it cannot assure compliance will be regained or maintained. It had received a Nasdaq bid price deficiency notification before the split. A 1-for-30 split took effect in April. The company has not announced a separate catalyst, and a market value near $1.5 million (calculated) follows from the split-adjusted share count.
Nasdaq Compliance Movers Compared: Who Is Closest to the Exit?
The six decliners averaged a 19.86% drop (calculated), while the two risers, Veea and BIO-key, averaged a 26.35% gain (calculated). Lunai Bioworks fell about 4.3 times as far as Founder Group (calculated), a gap of 33.01 percentage points (calculated).
Counting from October 23, Lunai's suspension on October 30 is 7 days away (calculated) and its delisting on or about November 12 is 20 days away (calculated). Its $9,024,946 deficit is about 3.6 times the $2.5 million equity minimum (calculated), a shortfall of about $11.5 million (calculated). A hearing requested October 23 would fall roughly between November 22 and December 7 under the 30 to 45 day pattern (calculated). Delixy's bid price matter ran 173 days from notice to closing letter (calculated), and the closing letter arrived 7 days before its deadline (calculated).
What to Watch Next: Which Compliance Deadlines Arrive First?
Atlantic American's hearing request was due October 23, 2026, with a 15-day stay to follow. Lunai Bioworks faces suspension on October 30, a Form 25 around November 2 and delisting around November 12. Hub Cyber Security has not announced a response to its September 23 notice, and Huachen must hold the bid price after its split. BIO-key remains under monitoring until July 6, 2027.
Lunai Bioworks and Atlantic American received staff delisting determinations, over stockholders' equity and late periodic reports respectively.
Trading is expected to be suspended on October 30, 2026, with delisting on or about November 12.
No. Six fell, while Veea rose 23.51% and BIO-key rose 29.19% without announced catalysts.






Please wait processing your request...